Collecting duct
Chen L, et al. Development and diseases of the collecting duct system. Res Probl Cell Differ 2017; 60:165–203. doi: 10.1007/978-3-319-51436-9_14 [Erratum: Res Probl Cell Differ 2017; 60:E1. doi: 10.1007/978-3-319-51436-9_14].
McMahon RS, et al. Anatomy, abdomen and pelvis: Kidney collecting ducts. In: StatPearls [Internet]. StatPearls Publishing; 2024.
Boughton C, et al. Mineralocorticoid hypertension and hypokalaemia induced by posaconazole. Endocrinol Diabetes Metab Case Rep 2018; 2018:17-0157. doi: 10.1530/EDM-17-0157
Ji HH, et al. Antifungal therapy with azoles induced the syndrome of acquired apparent mineralocorticoid excess: A literature and database analysis. Antimicrob Agents Chemother 2022; 66:e0166821. doi: 10.1128/AAC.01668-21
Pandit A, Schlondorff J. Posaconazole-induced apparent mineralocorticoid excess. Kidney Int Rep 2020; 5:2379–2382. doi: 10.1016/j.ekir.2020.09.025
Ellison DP, Thomas CP. Hereditary disorders of collecting duct sodium and potassium transport. In: Mount DB, Pollak MR, eds. Molecular and Genetic Basis of Renal Disease. Elsevier Saunders; 2008:251–268. https://www.sciencedirect.com/science/article/abs/pii/B9781416002529500203
Athimulam S, et al. Low-renin hypertension. Endocrinol Metab Clin North Am 2019; 48:701–715. doi: 10.1016/j.ecl.2019.08.003
Hattori T, et al. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury. Hypertens Res 2014; 37:125–133. doi: 10.1038/hr.2013.124